CMA Condemns FDA Use of Aborted Babies’ Tissue

Catholic Medical Association Condemns the U.S. Food and Drug Administration’s Use of Aborted Babies’ Tissue in Experiments

CMA is calling on Congress and the Trump Administration to immediately rescind contracts

PHILADELPHIA, PA– August 8, 2018 – CNSNews is reporting that the U.S. Food and Drug Administration signed a new contract last month to acquire “fresh” human fetal tissue to transplant into “humanized mice” proving the animals to have functioning “human immune systems,” according to information published by the FDA and the General Services Administration. The experiments would be funded with federal tax dollars.

“The FDA says the research using aborted babies is critical to understanding how the human immune system responds to certain drugs and biologics, helping to better understand diseases that affect millions of Americans. We strongly disagree. We oppose sacrificing any human life that justify this form of human experimentation,” said Stephen White, Chair of the CMA’s Health Care Policy Committee.
The FDA claims the experimentation requires tissue from late-term aborted babies, not miscarried ones to create its “humanized mice.”

“The use of unborn human life for experimentation by the United States government is unconscionable. We are calling for an immediate stop to this practice urging the Trump administration to revoke the contracts,” said CMA President Peter T. Morrow, M.D.

In fiscal 2018, the National Institutes of Health (NIH), a separate department from the FDA but also part of the Department of Health and Human Services (HHS) estimates it will spend $103 million on human fetal tissue research.

In July, the House Appropriations Committee approved a bill to fund the Department of Health and Human Services for fiscal 2019. That bill includes language that prohibits federal funding of research that uses human fetal tissue obtained through an abortion.
According to CNSNews for that language to become law, it would need to be included in a funding bill that is passed by both the House and Senate and signed by President Donald Trump.